Literature DB >> 3513601

Higher susceptibility of mast-cell-deficient W/WV mutant mice to brain thromboembolism and mortality caused by intravenous injection of India ink.

Y Kitamura, T Taguchi, M Yokoyama, M Inoue, A Yamatodani, H Asano, T Koyama, A Kanamaru, K Hatanaka, B K Wershil.   

Abstract

(WB X C57BL/6)F1-W/WV mice possess a genetic defect in multipotential hematopoietic stem cells; the mice are anemic and lack mast cells. The authors injected diluted India ink intravenously into W/WV mice and congenic normal +/+ mice and searched for genetically determined differences in the development of complications of the injection. In both W/WV and +/+ mice, intravenous ink resulted in thrombocytopenia and markedly prolonged bleeding times, as well as prolonged partial thromboplastin and prothrombin times and reduced fibrinogen concentrations. These effects were similar in W/WV and +/+ mice, although the reduction in platelet counts was greater in W/WV mice. In addition, the mortality associated with ink injection was significantly higher in W/WV mice than in congenic +/+ mice. Most W/WV mice which died first exhibited paralysis, and examination under the dissection microscope revealed that ink injection resulted in significantly more cerebral thromboemboli in W/WV mice than in +/+ controls. Bone marrow transplantation from +/+ mice corrected both the mast cell deficiency and the anemia of W/WV mice and protected the W/WV recipients from the adverse consequences of ink injection. By contrast, +/+ mice rendered as anemic as W/WV mice by breeding did not exhibit increased morbidity and mortality after ink injection. (WC X C57BL/6)F1-Sl/Sld mice, which are anemic and lack mast cells because of a genetic defect different from that of W/WV mice, also exhibited increased morbidity and mortality after intravenous ink. Finally, mixture of ink with commercial heparin prior to intravenous injection markedly reduced the incidence of cerebral thromboembolism and death in W/WV mice. Taken together, these findings suggest that the increased morbidity and mortality exhibited by W/WV and Sl/Sld mice that received injected ink might be related to their mast cell deficiency rather than to their anemia. But measurement of the histamine content of the blood and various tissues of WBB6F1-+/+ mice injected with ink, and examination of their tissues in 1-mu sections, indicated that intravenous ink did not cause substantial mast cell degranulation. As a result, the possibility that mast cells protect +/+ mice from the adverse effects of intravenous ink by a mechanism other than degranulation and release of heparin, or that the differences in the response of W/WV or Sl/Sld mice and their +/+ littermates are due to defects other than their lack of mast cells, cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3513601      PMCID: PMC1888208     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Quantitative study of the granulopectic activity of the reticulo-endothelial system. I. The effect of the ingredients present in India ink and of substances affecting blood clotting in vivo on the fate of carbon particles administered intravenously in rats, mice and rabbits.

Authors:  B N HALPERN; B BENACERRAF; G BIOZZI
Journal:  Br J Exp Pathol       Date:  1953-08

2.  [Quantitative study of the granulopexy activity of the reticuloendothelial system by intravenous injection of India ink in different animal species. I. Method of quantitative study of the granulopexy activity of the reticuloendothelial system by intravenous injection of carbon particles of known dimensions].

Authors:  B N HALPERN; G BIOZZI; G MENE; B BENACERRAF
Journal:  Ann Inst Pasteur (Paris)       Date:  1951-06

3.  Immunologic release of heparin from purified rat peritoneal mast cells.

Authors:  R W Yurt; R W Leid; J Spragg; K F Austen
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

Review 4.  Hereditary anemias of the mouse: a review for geneticists.

Authors:  E S Russell
Journal:  Adv Genet       Date:  1979       Impact factor: 1.944

5.  Changed differentiation pattern of parental colony-- forming cells in F1 hybrid mice suffering from graft-versus-host disease.

Authors:  Y Kitamura; T Kawata; O Suda; K Ezumi
Journal:  Transplantation       Date:  1970-12       Impact factor: 4.939

6.  Highly purified antithrombin 3 with heparin cofactor activity prepared by disc electrophoresis.

Authors:  U Abildgaard
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

7.  Decreased neutrophils and megakaryocytes in anemic mice of genotype W/W.

Authors:  P A Chervenick; D R Boggs
Journal:  J Cell Physiol       Date:  1969-02       Impact factor: 6.384

8.  Experimental model of disseminated intravascular coagulation induced by sustained infusion of endotoxin.

Authors:  T Yoshikawa; Y Furukawa; M Murakami; S Takemura; M Kondo
Journal:  Res Exp Med (Berl)       Date:  1981

9.  Regulation of megakaryocytes in W/Wv mice.

Authors:  S Ebbe; E Phalen
Journal:  J Cell Physiol       Date:  1978-07       Impact factor: 6.384

10.  The significance of mast cells as a source of histamine in the mouse brain.

Authors:  E L Orr; K R Pace
Journal:  J Neurochem       Date:  1984-03       Impact factor: 5.372

View more
  4 in total

1.  Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo.

Authors:  S J Galli; Y Kitamura
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

2.  Immunological modulation of human cardiac mast cells.

Authors:  G Marone; G de Crescenzo; G Florio; F Granata; V Dente; A Genovese
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

3.  Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.

Authors:  Sabine Cerny-Reiterer; Anja Rabenhorst; Gabriele Stefanzl; Susanne Herndlhofer; Gregor Hoermann; Leonhard Müllauer; Sigrid Baumgartner; Christine Beham-Schmid; Wolfgang R Sperr; Christine Mannhalter; Heinz Sill; Werner Linkesch; Michel Arock; Karin Hartmann; Peter Valent
Journal:  Oncotarget       Date:  2015-02-20

Review 4.  Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts.

Authors:  Peter Valent; Cem Akin; Karin Hartmann; Gunnar Nilsson; Andreas Reiter; Olivier Hermine; Karl Sotlar; Wolfgang R Sperr; Luis Escribano; Tracy I George; Hanneke C Kluin-Nelemans; Celalettin Ustun; Massimo Triggiani; Knut Brockow; Jason Gotlib; Alberto Orfao; Petri T Kovanen; Emir Hadzijusufovic; Irina Sadovnik; Hans-Peter Horny; Michel Arock; Lawrence B Schwartz; K Frank Austen; Dean D Metcalfe; Stephen J Galli
Journal:  Theranostics       Date:  2020-08-29       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.